TITLE

Jim Warren interviews Charlie Alexander, Living Legacy CEO, on OPO's full face organ recovery process; how they did what they did

AUTHOR(S)
Warren, Jim
PUB. DATE
April 2012
SOURCE
Transplant News;Apr2012, Vol. 22 Issue 4, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Interview
ABSTRACT
An interview with chief executive officer (CEO) Charlie Alexander of Living Legacy is presented. When asked on the call from a suitable donor for patient with vascular composite allograph (VCA), he says that the patient admitted with devastating neurological injury on March 16, 2012 is confirmed to be a suitable donor. He mentions that the incident is a normal standard approach for donor authorization. He states that the family of the donor has given the authorization for the face recovery.
ACCESSION #
76173125

 

Related Articles

  • Anti-LRP4 Myasthenia Gravis. Rubin, Michael // Neurology Alert;Jul2013, Vol. 31 Issue 11, p81 

    AMONG PATIENTS WITH MYASTHENIA GRAVIS (MG), APPROXIMATELY HAVE 80% serum autoantibodies directed against the nicotinic acetylcholine receptor, 5-10% have autoantibodies directed against the tyrosine kinase muscle-specific kinase (MuSK), and, in the remainder, the autoimmune target is unknown....

  • Demyelinating disease. YAN Xiao-ling // Chinese Journal of Contemporary Neurology & Neurosurgery;Jun2013, Vol. 13 Issue 6, p549 

    No abstract available.

  • Acute Seizures and Epilepsy Risk in Pediatric Intracerebral Hemorrhage. Keros, Sotirios // Neurology Alert;Jun2013, Vol. 31 Issue 10, p77 

    SPONTANEOUS INTRACRANIAL HEMORRHAGE (ICH) IS A KNOWN risk factor for acute seizures as well as the subsequent development of epilepsy. The association between seizures and ICH appears to be particularly strong in children and neonates relative to adults. The existing pediatric data are somewhat...

  • Atypical meningioma. YAN Xiao-ling // Chinese Journal of Contemporary Neurology & Neurosurgery;Mar2013, Vol. 13 Issue 3, p254 

    No abstract available.

  • Research and application progress of MGMT promoter methylation in gliomas. SUN Cui-yun; YU Shi-zhu // Chinese Journal of Contemporary Neurology & Neurosurgery;Jul2014, Vol. 14 Issue 7, p638 

    O6 -methylguanine-DNA methyltransferase (MGMT) is an important DNA repair enzyme. The promoter methylation status of MGMT gene has recently become a biomarker of gliomas. Methylation of the MGMT promoter not only is an important biomarker to evaluate the sensitivity to the chemotherapy with...

  • Neurofibroma. YAN Xiao-ling // Chinese Journal of Contemporary Neurology & Neurosurgery;Jul2014, Vol. 14 Issue 7, p642 

    No abstract available.

  • A 58-year-old female with blurred vision and apraxia. SHI Zhi-hong; CAI Li; LIU Shuai; WANG Ying; LIU Shu-ling; JI Yong // Chinese Journal of Contemporary Neurology & Neurosurgery;Jul2014, Vol. 14 Issue 7, p643 

    No abstract available.

  • Some suggestions of etiological diagnosis of tuberculous meningitis. SU Xiu-chu; ZHAO Gang; FENG Guo-dong; YANG Yi-ning; DAI Wen; LIU Ting-ting // Chinese Journal of Contemporary Neurology & Neurosurgery;Aug2014, Vol. 14 Issue 8, p655 

    No abstract available.

  • Paraganglioma. YAN Xiao-ling // Chinese Journal of Contemporary Neurology & Neurosurgery;Dec2014, Vol. 14 Issue 12, p1090 

    No abstract available.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics